Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Rocuronium Bromide Injection

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,190Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Farmhispania
    Spain
    		 Pamirae Co., Ltd. 20190118-210-J-304 Rocuronium bromide 2019-01-18 FARMHISPANIA, SA Spain Passeig del Riu Besos, 9-10, 08160 MONTMELO (BARCELONA), SPAIN
    29/11/2025 Farmhispania
    Spain
    		 Hana Pharmaceutical Co., Ltd. 20190118-210-J-304(1) Rocuronium bromide 2019-11-26 FARMHISPANIA, SA Spain Passeig del Riu Besos, 9-10, 08160 MONTMELO (BARCELONA), SPAIN